Page 201 - 110413CHI_BR_DF_JB_ID11494_FinalCut_ABC_send_15_WEBblaetter_kl

201 Jahresbericht 2008 – 2009

mann St: Increased alternative splicing of the KLF6 tumour suppressor gene correlates with prognosis and tumour grade in patients with pancreatic cancer. Eur J Cancer. 44(13):1895-903. 4,167

54. Hartwig W, Schimmel E, Hackert T, Fortunato F, Bergmann F, Baczako A, Strobel O, Büchler MW, Werner J: A novel animal model of se-vere pancreatitis in mice and its differences to the rat. Surgery. 144(3):394-403. 2,977 55. Hartwig W, Strobel O, Lordick F, Büchler MW, Werner J: Multimodale Therapie des Ösopha-guskarzinoms. Z Gastroenterol. 46(10): 1207-13. 1,293

56. Hartwig W, Strobel O, Schneider L, Hackert T, Hesse C, Büchler MW, Werner J: Fundus Rotation Gastroplasty vs: Kirschner-Akiyama Gastric Tube in Esophageal Resection: Com-parison of Perioperative and Long-Term Re-sults. World J Surg. 32(8):1695-702. 1,765 57. Haug U, Wente MN, Seiler CM, Jesnowski R, Brenner H: Stool testing for the early de-tection of pancreatic cancer: rationale and cur rent evidence. Exper t Rev Mol Diagn. 8(6):753-759. 2,438

58. Heger U, Büchler MW, Weitz J: Übersicht - Di-agnostik des Pankreaskarzinoms. Tumor Di-agnostik & Therapie. 5(29) 246-250

59. Heger U, Weitz J, Lordick F: Indikationen zur prä- und postoperativen Therapie mit Imati-nib bei gastrointestinalen Stromatumoren Chirurg. 79(7):630-7. 0,489

60. Hennig R, Osman T, Esposito I, Giese N, Rao SM, Ding XZ, Tong WG, Büchler MW, Yokomi-zo T, Friess H, Adrian TE: BLT2 is expressed in PanINs, IPMNs, pancreatic cancer and stimu-lates tumour cell proliferation. Brit J Cancer 99(7):1064-73. 4,459

61. Hofer S, Eisenbach C, Lukic IK, Schneider L, Bode K, Brueckmann M, Mautner S, Wente MN, Encke J, Werner J, Dalpke AH, Strem-mel W, Nawroth PP, Martin E, Krammer PH, Bierhaus A, Weigand MA: Pharmacologic cholinesterase inhibition improves survival in experimental sepsis. Crit Care Med. 36(2): 404-8. 6. 599

62. Hof fmann K, Bekeredjian R, Schmidt J , Büchler MW, Märten A: Effects of the High-Aff inity Peptide Reversin 121 on Multidrug Resistance Proteins in Experimental Pancre-atic Cancer. Tumor Biol. 29(6):351-358. 2,407

63. Hoffmann K, Glimm H, Radeleff B, Richter G, Heining C, Schenkel I, Zahlten-Hinguranage A, Schirmacher P, Schmidt J, Büchler MW, Ja-eger D, Kalle CV, Schemmer P: Prospective, randomized, double-blind, multi-center, Phase III clinical study on transarterial che-moembolization (TACE) combined with So-rafenib versus TACE plus placebo in patients with hepatocellular cancer before liver trans-plantation- HeiLivCa [ISRCTN24081794]: BMC Cancer. 8(1):349. 2,359

64. Hoffmann K, Hermanns-Clausen M, Buhl C, Büchler MW, Schemmer P, Mebs D, Kaufer-stein S: A case of palytoxin poisoning due to contact with zoanthid corals through a skin injury. Toxicon. 51(8):1535-7. 2,977

65. Hoffmann K, Mehrle S, Schmidt J, Büchler MW, Märten A: Interferon-alpha restitutes the chemosensitivity in pancreatic cancer. Anticancer Res. 28(3A): 1499-507. 1,479 66. Hosch W, Stojkovic M, Jaenisch t, Heye T, Werner J, Friess H, Kauf fmann GW, Jung-hanss T: MR imaging for diagnosing cysto-biliary fistulas in cystic echinococcosis. EUR J RADIOL. 66(2): 262-7. 1,332

67. Huber FX, Berger I, McArthur N, Huber C, Kock HP, Hillmeier J, Meeder PJ: Evaluation of a no-vel nanocrystalline hydroxyapatite paste and a solid hydroxyapatite ceramic for the treat-ment of critical size bone defects (CSD) in rabbits. J Mater Sci-Mater M. 19(1): 33-8. 1,562 68. Huber FX, Hillmeier J, Kock HJ, McArthur N, Huber C, Diwo M, Baier M, Meeder PJ: Filling of metaphyseal defects with nanocrystalline hydroxyapatite (ostim(r)) for fractures of the radius. ZBL Chir. 133(6):577-81. 0,548 69. Jiang X, Abiatari I, Kong B, Erkan M, De Oliveira T, Giese NA, Michalski CW, Friess H, Kleeff J: Pancreatic Islet and Stellate Cells Are the Main Sources of Endocrine Gland-Derived Vascular Endothelial Growth Factor/ Prokineticin-1 in Pancreatic Cancer: Pancre-atology. 9(1-2):165-172. 2,147. 9(1-2). 165-72 70. Jiang X, Zhang W, Kayed H, Zheng P, Giese NA, Friess H, Kleeff J: Loss of ONECUT1 ex-pression in human pancreatic cancer Cells. Oncol Rep. 19(1):157-63. 1,567

71. Joos S, Eicher C, Musselmann B, Kadmon M: Entwicklung, Implementierung und Evaluation eines `Cirriculums Naturheilverfahren`an der Universität Heidelberg. Forsch Komplement-med. 15(5):251-60